This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hameln Pharma Gmbh. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: Norbert Varga: Innovator in Pharmaceutical Chemistry
Introduction
Norbert Varga is a notable inventor based in Modra, Slovakia. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds used in medical applications.
Latest Patents
Varga holds a patent for "Intermediates for the preparation of remifentanil hydrochloride." This patent introduces a new intermediate for synthesizing 1-substituted-4-[phenyl(propanoyl)amino]piperidine-4-carbonitrile derivatives. The method outlined in the patent offers a more efficient process for preparing remifentanil, resulting in greater yields and higher purity compared to previous methods.
Career Highlights
Norbert Varga is currently employed at Hameln Pharma GmbH, where he continues to innovate in the pharmaceutical sector. His work focuses on developing new methods and intermediates that enhance the efficiency of drug synthesis.
Collaborations
Varga collaborates with talented coworkers, including Pavol Valachovic and Janka Králová, who contribute to his research and development efforts.
Conclusion
Norbert Varga's contributions to pharmaceutical chemistry, particularly through his patent on remifentanil synthesis, highlight his role as an innovator in the field. His work continues to impact the efficiency and purity of pharmaceutical products.